Gastrointestinal Involvement in Systemic Sclerosis : Overview, Neglected Aspects, Malnutrition, Body Composition and Management

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000027" target="_blank" >RIV/00023728:_____/19:N0000027 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/gastrointestinal-involvement-in-systemic-sclerosis-overview-neglected-aspects-malnutrition-body-comp" target="_blank" >https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/gastrointestinal-involvement-in-systemic-sclerosis-overview-neglected-aspects-malnutrition-body-comp</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5772/intechopen.88286" target="_blank" >10.5772/intechopen.88286</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Gastrointestinal Involvement in Systemic Sclerosis : Overview, Neglected Aspects, Malnutrition, Body Composition and Management

Popis výsledku v původním jazyce

Gastrointestinal tract (GIT) involvement is the most common internal organ manifestation and is present in up to 90% of patients with systemic sclerosis (SSc). Clinical manifestations can differ according to the part of the GIT affected, disease course and symptoms. A majority of the symptoms are caused by GIT dysmotility. Up to 8% of SSc patients develop several GIT symptoms, which increase the mortality. Although GIT involvement is rarely the direct cause of death, it can lead to several comorbidities including malnutrition and negative alterations of body composition. These factors have a negative impact on quality of life and increase the mortality. To date, the treatment is rather symptomatic. The pathogenesis of GIT involvement in SSc still remains to be clarified to improve the treatment approaches including intravenous immunoglobulins and microRNA interventions

Název v anglickém jazyce

Gastrointestinal Involvement in Systemic Sclerosis : Overview, Neglected Aspects, Malnutrition, Body Composition and Management

Popis výsledku anglicky

Gastrointestinal tract (GIT) involvement is the most common internal organ manifestation and is present in up to 90% of patients with systemic sclerosis (SSc). Clinical manifestations can differ according to the part of the GIT affected, disease course and symptoms. A majority of the symptoms are caused by GIT dysmotility. Up to 8% of SSc patients develop several GIT symptoms, which increase the mortality. Although GIT involvement is rarely the direct cause of death, it can lead to several comorbidities including malnutrition and negative alterations of body composition. These factors have a negative impact on quality of life and increase the mortality. To date, the treatment is rather symptomatic. The pathogenesis of GIT involvement in SSc still remains to be clarified to improve the treatment approaches including intravenous immunoglobulins and microRNA interventions

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

30226 - Rheumatology

Projekt

<a href="/cs/project/NV18-01-00161" target="_blank" >NV18-01-00161: Ateroskleróza a kardiovaskulární riziko u vybraných revmatických onemocnění</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

New Insights into Systemic Sclerosis

ISBN

978-1-83962-204-5

Počet stran výsledku

24

Strana od-do

63-86

Počet stran knihy

148

Název nakladatele

IntechOpen

Místo vydání

London

Kód UT WoS kapitoly

—